老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioLine Rx

2.88
+0.13404.88%
盘后：2.74-0.1400-4.86%17:36 EDT
成交量：8,878.00
成交额：2.47万
市值：1,071.65万
市盈率：-0.62
高：2.88
开：2.75
低：2.74
收：2.75
数据加载中...
总览公司新闻公告
2020/01/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/05

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/30

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/07/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/05

[修订]年度报告

[Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/05/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/01

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/02/11

SEC问询函

[Cover]Correspondence
更多